United States Biotechnology & Medical Research

InterMune Inc (ITMN)

Track

Ticker: ITMN Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 2 Sep 2014
Value US$2,850,541.71 | Price 391.01 | Shares 92,862 (+28.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2014-09-03 2014-09-02 PlS Planned sale Powell Andrew Kenneth William

EVP, GC & Secretary

Officer
92,862 +28.0%
391.01
US$2,850,542 		92,862 +28.0% 391.01 US$2,850,542
2014-08-20 2014-08-15 PlS Planned sale Di Nepi Giacomo

EVP Managing Director, Europe

Officer
67,945 +8.4%
17.84
US$546,908 		67,945 +8.4% 17.84 US$546,908
2014-08-14 2014-08-13 PlS Planned sale ARATA PAUL D

EVP, Human Resources & Admin

Officer
58,557 +3.1%
430.86
US$3,175,234 		58,557 +3.1% 430.86 US$3,175,234
2014-08-14 2014-08-13 PlS Planned sale Nolan Sean P.

EVP & CBO

Officer
17,000 -20.6%
50.00
US$850,000 		17,000 -20.6% 50.00 US$850,000
2014-08-07 2014-08-07 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
24,900 -20.9%
45.17
US$1,124,813 		24,900 -20.9% 45.17 US$1,124,813
2014-08-07 2014-08-05 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
146,125 -60.8%
44.95
US$6,568,684 		146,125 -60.8% 44.95 US$6,568,684
2014-07-17 2014-07-15 PlS Planned sale Leff Jonathan A

EVP, Research & Development

Officer
35,000 -43.1%
43.08
US$1,507,709 		35,000 -43.1% 43.08 US$1,507,709
2014-06-20 2014-06-18 PlS Planned sale Nolan Sean P.

EVP & CBO

Officer
10,000 -13.2%
47.10
US$471,000 		10,000 -13.2% 47.10 US$471,000
2014-06-18 2014-06-16 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
15,000 -13.7%
45.02
US$675,252 		15,000 -13.7% 45.02 US$675,252
2014-06-13 2014-06-13 PlS Planned sale Nolan Sean P.

EVP & CBO

Officer
10,000 -13.2%
44.35
US$443,500 		10,000 -13.2% 44.35 US$443,500
2014-06-13 2014-06-06 PlS Planned sale Nolan Sean P.

EVP & CBO

Officer
10,000 -13.2%
41.25
US$412,500 		10,000 -13.2% 41.25 US$412,500
2014-08-20 2014-06-04 S Sale Di Nepi Giacomo

EVP Managing Director, Europe

Officer
12,085 -29.7%
39.79
US$480,902 		12,085 -29.7% 39.79 US$480,902
2014-06-03 2014-05-30 S Sale Powell Andrew Kenneth William

EVP, GC & Secretary

Officer
500 -1.6%
39.32
US$19,662 		500 -1.6% 39.32 US$19,662
2014-06-03 2014-05-29 S Sale Powell Andrew Kenneth William

EVP, GC & Secretary

Officer
500 -1.6%
39.56
US$19,780 		500 -1.6% 39.56 US$19,780
2014-06-02 2014-05-29 S Sale KABAKOFF DAVID S Non-Executive Director
5,000 -18.8%
39.56
US$197,800 		5,000 -18.8% 39.56 US$197,800
2014-05-28 2014-05-27 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
6,949 -6.9%
40.15
US$278,970 		6,949 -6.9% 40.15 US$278,970
2014-06-04 2014-05-23 PlS Planned sale ARATA PAUL D

EVP, Human Resources & Admin

Officer
10,000 -30.5%
40.00
US$400,000 		10,000 -30.5% 40.00 US$400,000
2014-05-28 2014-05-23 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
34,544 -26.9%
40.01
US$1,381,974 		34,544 -26.9% 40.01 US$1,381,974
2014-05-21 2014-05-19 PlS Planned sale WELCH DANIEL G

Charman, CEO and President

Executive Director
11,607 -11.0%
38.00
US$441,066 		11,607 -11.0% 38.00 US$441,066
2014-05-07 2014-05-06 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
31,519 -24.3%
36.01
US$1,135,012 		31,519 -24.3% 36.01 US$1,135,012
2014-05-07 2014-05-05 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
28,913 -22.8%
33.39
US$965,370 		28,913 -22.8% 33.39 US$965,370
2014-03-05 2014-03-04 PlS Planned sale Leff Jonathan A

EVP of R&D

Officer
20,000 -30.0%
31.51
US$630,286 		20,000 -30.0% 31.51 US$630,286
2014-03-05 2014-03-04 S Sale Di Nepi Giacomo

EVP, Managing Director, Europe

Officer
70,000 -72.6%
30.84
US$2,158,695 		70,000 -72.6% 30.84 US$2,158,695
2014-02-27 2014-02-25 PlS Planned sale HODGMAN JOHN

EVP-Finance & CFO

Officer
73,130 -73.6%
35.69
US$2,610,010 		73,130 -73.6% 35.69 US$2,610,010
2014-02-27 2014-02-25 PlS Planned sale HODGMAN JOHN

EVP-Finance & CFO

Officer
86,355 -46.5%
35.69
US$3,082,010 		86,355 -46.5% 35.69 US$3,082,010
2014-02-27 2014-02-25 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
41,087 -23.0%
32.63
US$1,340,767 		41,087 -23.0% 32.63 US$1,340,767
2013-10-03 2013-10-01 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
70,000 -30.8%
15.43
US$1,080,016 		70,000 -30.8% 15.43 US$1,080,016
2013-09-04 2013-08-30 S Sale KABAKOFF DAVID S
10,002 -24.7%
14.82
US$148,245 		10,002 -24.7% 14.82 US$148,245
2013-08-28 2013-08-27 B Purchase Russell Angus C. Non-Executive Director
4,950 +53.8%
14.37
US$71,130 		4,950 +53.8% 14.37 US$71,130
2013-08-28 2013-08-26 B Purchase Russell Angus C. Non-Executive Director
1,650 +21.8%
15.00
US$24,743 		1,650 +21.8% 15.00 US$24,743
2011-07-27 2011-07-27 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
1,800 -2.8%
35.16
US$63,286 		1,800 -2.8% 35.16 US$63,286
2011-07-21 2011-07-20 PlS Planned sale Porter Steven Bryant

Chief Medical Officer

Officer
7,290 -14.1%
36.25
US$264,242 		7,290 -14.1% 36.25 US$264,242
2011-07-21 2011-07-20 PlS Planned sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
7,250 -14.0%
36.23
US$262,694 		7,250 -14.0% 36.23 US$262,694
2011-07-14 2011-07-13 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
6,000 -8.9%
35.97
US$215,848 		6,000 -8.9% 35.97 US$215,848
2011-07-07 2011-07-06 PlS Planned sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
7,250 -14.0%
35.84
US$259,838 		7,250 -14.0% 35.84 US$259,838
2011-07-07 2011-07-06 PlS Planned sale Porter Steven Bryant

Chief Medical Officer

Officer
7,290 -14.1%
35.82
US$261,118 		7,290 -14.1% 35.82 US$261,118
2011-06-30 2011-06-29 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
6,000 -8.9%
35.47
US$212,836 		6,000 -8.9% 35.47 US$212,836
2011-06-23 2011-06-22 PlS Planned sale Porter Steven Bryant

Chief Medical Officer

Officer
7,290 -14.1%
32.03
US$233,462 		7,290 -14.1% 32.03 US$233,462
2011-06-23 2011-06-22 PlS Planned sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
7,250 -14.0%
35.02
US$253,909 		7,250 -14.0% 35.02 US$253,909
2011-06-23 2011-06-21 PlS Planned sale Porter Steven Bryant

Chief Medical Officer

Officer
7,290 -14.1%
35.00
US$255,150 		7,290 -14.1% 35.00 US$255,150
2011-06-23 2011-06-21 PlS Planned sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
7,250 -14.0%
35.00
US$253,750 		7,250 -14.0% 35.00 US$253,750
2011-06-23 2011-06-21 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
6,000 -8.9%
35.00
US$210,000 		6,000 -8.9% 35.00 US$210,000
2011-06-22 2011-06-20 S Sale Seiwert Scott

SVP, Rsearch & Technical Dev.

Officer
6,297 -14.0%
33.22
US$209,188 		6,297 -14.0% 33.22 US$209,188
2011-06-22 2011-06-20 S Sale Seiwert Scott

SVP, Rsearch & Technical Dev.

Officer
23,891 -34.6%
33.15
US$791,987 		23,891 -34.6% 33.15 US$791,987
2011-06-22 2011-06-20 S Sale Porter Steven Bryant

Chief Medical Officer

Officer
7,321 -14.1%
34.00
US$248,914 		7,321 -14.1% 34.00 US$248,914
2011-06-22 2011-06-20 S Sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
7,321 -14.1%
34.00
US$248,914 		7,321 -14.1% 34.00 US$248,914
2011-06-21 2011-06-17 S Sale Steele Robin Joan

SVP, GC, Secretary

Officer
38,721 -71.4%
33.78
US$1,307,995 		38,721 -71.4% 33.78 US$1,307,995
2011-06-15 2011-06-14 S Sale Cohen Alan Howard

SVP, Medical Affairs

Officer
20,849 -50.6%
33.00
US$688,017 		20,849 -50.6% 33.00 US$688,017
2011-06-15 2011-06-14 S Sale Simon Howard Allan

SVP-Human Resources

Officer
21,213 -46.8%
33.00
US$700,029 		21,213 -46.8% 33.00 US$700,029
2011-06-10 2011-06-08 S Sale Simon Howard Allan

SVP-Human Resources

Officer
9,578 -23.7%
33.00
US$316,074 		9,578 -23.7% 33.00 US$316,074
2011-06-10 2011-06-08 S Sale Simon Howard Allan

SVP-Human Resources

Officer
21,176 -34.4%
32.64
US$691,123 		21,176 -34.4% 32.64 US$691,123
2011-06-03 2011-06-02 S Sale KABAKOFF DAVID S Non-Executive Director
2,000 -3.8%
36.41
US$72,819 		2,000 -3.8% 36.41 US$72,819
2011-06-02 2011-06-01 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
6,000 -8.3%
36.79
US$220,724 		6,000 -8.3% 36.79 US$220,724
2011-06-02 2011-06-01 S Sale Porter Steven Bryant

Chief Medical Officer

Officer
3,226 -5.4%
37.01
US$119,379 		3,226 -5.4% 37.01 US$119,379
2011-06-02 2011-06-01 S Sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
3,186 -5.4%
36.50
US$116,301 		3,186 -5.4% 36.50 US$116,301
2011-06-01 2011-05-31 S Sale Cohen Alan Howard

SVP, Medical Affairs

Officer
36,189 -57.3%
37.16
US$1,344,762 		36,189 -57.3% 37.16 US$1,344,762
2011-05-20 2011-05-18 S Sale Simon Howard Allan

SVP-Human Resources

Officer
109,656 -73.1%
38.78
US$4,252,602 		109,656 -73.1% 38.78 US$4,252,602
2011-05-19 2011-05-18 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
6,000 -8.3%
37.17
US$223,018 		6,000 -8.3% 37.17 US$223,018
2011-05-19 2011-05-18 PlS Planned sale Porter Steven Bryant

Chief Medical Officer

Officer
1,811 -3.0%
37.05
US$67,095 		1,811 -3.0% 37.05 US$67,095
2011-05-19 2011-05-18 PlS Planned sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
1,822 -3.0%
37.22
US$67,822 		1,822 -3.0% 37.22 US$67,822
2011-05-18 2011-05-18 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
20,750 -7.4%
37.22
US$772,323 		20,750 -7.4% 37.22 US$772,323
2011-05-18 2011-05-17 S Sale Di Nepi Giacomo

SVP, Managing Director, Europe

Officer
39,939 -61.9%
37.75
US$1,507,817 		39,939 -61.9% 37.75 US$1,507,817
2011-05-18 2011-05-16 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
3,505 -1.2%
38.22
US$133,961 		3,505 -1.2% 38.22 US$133,961
2011-05-18 2011-05-16 S Sale Bradford Williamson Z III

SVP-Clinical Science

Officer
958 -1.4%
37.78
US$36,193 		958 -1.4% 37.78 US$36,193
2011-05-16 2011-05-13 S Sale Bradford Williamson Z III

SVP-Clinical Science

Officer
1,918 -2.8%
39.85
US$76,425 		1,918 -2.8% 39.85 US$76,425
2011-05-16 2011-05-12 PlS Planned sale Steele Robin Joan

SVP, GC, Secretary

Officer
187,887 -75.3%
38.59
US$7,250,315 		187,887 -75.3% 38.59 US$7,250,315
2011-05-16 2011-05-12 S Sale HODGMAN JOHN

SVP-Finance & CFO

Officer
143,227 -86.7%
40.00
US$5,729,080 		143,227 -86.7% 40.00 US$5,729,080
2011-05-16 2011-05-12 S Sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
131,332 -69.2%
40.14
US$5,271,732 		131,332 -69.2% 40.14 US$5,271,732
2011-05-16 2011-05-12 S Sale Bradford Williamson Z III

SVP-Clinical Science

Officer
115,842 -63.2%
38.84
US$4,499,118 		115,842 -63.2% 38.84 US$4,499,118
2011-05-16 2011-05-12 S Sale Porter Steven Bryant

Chief Medical Officer

Officer
88,311 -60.1%
38.89
US$3,434,256 		88,311 -60.1% 38.89 US$3,434,256
2011-05-16 2011-05-12 S Sale Seiwert Scott

SVP, Rsearch & Technical Dev.

Officer
71,443 -60.3%
39.13
US$2,795,229 		71,443 -60.3% 39.13 US$2,795,229
2011-05-05 2011-05-04 PlS Planned sale Porter Steven Bryant

Chief Medical Officer

Officer
5,500 -8.7%
44.03
US$242,164 		5,500 -8.7% 44.03 US$242,164
2011-05-05 2011-05-04 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
6,000 -8.3%
44.09
US$264,565 		6,000 -8.3% 44.09 US$264,565
2011-05-05 2011-05-04 PlS Planned sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
5,651 -8.9%
44.03
US$248,816 		5,651 -8.9% 44.03 US$248,816
2011-04-21 2011-04-20 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
6,000 -8.3%
46.43
US$278,606 		6,000 -8.3% 46.43 US$278,606
Explore more

More insider trading research around InterMune Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America